KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
16.43
+0.03 (0.18%)
Dec 5, 2025, 4:00 PM EST - Market closed
KalVista Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 5, 2025 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 | Apr '21 Apr 30, 2021 |
| Market Capitalization | 830 | 685 | 479 | 291 | 312 | 607 | |
| Market Cap Growth | 112.34% | 42.97% | 64.29% | -6.71% | -48.53% | 211.76% | |
| Enterprise Value | 777 | 538 | 411 | 128 | 126 | 558 | |
| Last Close Price | 16.43 | 13.77 | 11.35 | 8.53 | 12.73 | 24.97 | |
| PS Ratio | 582.38 | - | - | - | - | - | |
| PB Ratio | 20.28 | 7.18 | 2.32 | 1.81 | 1.69 | 2.36 | |
| P/TBV Ratio | 20.36 | 7.18 | 2.32 | 1.81 | 1.69 | 2.36 | |
| EV/Sales Ratio | 545.21 | - | - | - | - | - | |
| Debt / Equity Ratio | 3.40 | 1.18 | 0.04 | 0.05 | 0.04 | 0.02 | |
| Asset Turnover | 0.01 | - | - | - | - | - | |
| Quick Ratio | 5.16 | 5.22 | 9.70 | 11.18 | 15.81 | 26.67 | |
| Current Ratio | 5.37 | 5.35 | 9.90 | 11.46 | 16.73 | 27.04 | |
| Return on Equity (ROE) | -190.18% | -121.50% | -68.90% | -53.69% | -37.23% | -27.13% | |
| Return on Assets (ROA) | -60.98% | -48.34% | -41.94% | -35.80% | -25.38% | -19.86% | |
| Return on Capital (ROIC) | -70.75% | -55.75% | -45.82% | -38.23% | -26.46% | -20.78% | |
| Return on Capital Employed (ROCE) | -114.50% | -91.40% | -66.10% | -65.90% | -50.20% | -22.10% | |
| Earnings Yield | -24.46% | -26.80% | -26.45% | -31.88% | -26.35% | -7.62% | |
| FCF Yield | -20.22% | -22.40% | -18.64% | -26.23% | -25.31% | -4.98% | |
| Buyback Yield / Dilution | -29.51% | -34.98% | -31.89% | -13.96% | -28.17% | -7.58% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.